Astria Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
4.04
0.06
(1.51%)
Volume:
202,267
52 week range:
3.56 - 12.92
Market Cap:
226.891M
Company Description:
Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema.